For a heart rhythm problem and weak kidneys, apixaban showed the better balance

If you or someone you love has atrial fibrillation (AFib), an irregular heart rhythm, along with advanced kidney disease, the question of a blood thinner can feel tangled. A large new study sheds some light. Of the two blood thinners it looked at, apixaban gave the better balance between preventing strokes and causing bleeding.

The choice still belongs to you and your doctors. What this study gives you is a clearer picture to bring to that talk.

Why is this such a tricky decision?

AFib raises the chance of a stroke caused by a blood clot. Blood thinners lower that chance. But they also make serious bleeding more likely, and advanced kidney disease already makes people bleed more easily.

Because of that, people with severe kidney disease were left out of most earlier trials. Doctors have had little solid evidence to go on.

How the study worked

Researchers looked at US insurance records from Medicare and a large private insurer, covering adults with AFib and stage 4 or 5 kidney disease who were not on dialysis. They compared a large group who started apixaban with 6,335 who started warfarin and another large group who took no blood thinner, and they followed who had serious bleeding or a stroke. It was published in September 2026 in JAMA Network Open. Because people were not assigned to a treatment at random, the results show links, not proof of cause.

What they found

Compared with taking no blood thinner, apixaban went with fewer strokes caused by clots. The stroke rate was less than half as high. That works out to 12.67 fewer strokes for every 1,000 people followed for a year.

The trade-off was bleeding. Hospital stays for major bleeding were more common with apixaban, by 17.16 extra cases for every 1,000 people followed for a year. When the researchers added strokes and major bleeding together, there was no clear difference between taking apixaban and taking nothing.

Warfarin looked different. It went with more than twice as much major bleeding as no blood thinner, and no clear drop in strokes. Overall, people on warfarin did worse on the combined measure.

When the two drugs were compared head to head, apixaban came out ahead. People on apixaban had about half as much major bleeding and about half as many strokes as people on warfarin.

What does this mean for you?

Three takeaways:

• A blood thinner can lower stroke, but with advanced kidney disease it also brings more bleeding. Both sides of the scale matter.
• If a blood thinner is the right call for you, this study points to apixaban as the better-balanced choice over warfarin.
• Your own stroke and bleeding picture is what decides it, and your cardiologist and kidney doctor know that picture best.

You do not need to sort through the statistics yourself. You can arrive at the appointment knowing what to ask.

What you can do today

Open the notes app on your phone or grab a scrap of paper and write down two questions for your next appointment: “Given my kidneys and my heart rhythm, is a blood thinner right for me?” and “If so, is apixaban an option?” Keep the note where you will see it, and bring your current medication list along.